An oral tyrosine kinase inhibitor targeting HER2 exon 20 insertions and kinase domain mutations in solid tumors, designed for non-small cell lung cancer patients.

A small molecule histone deacetylase inhibitor that promotes tumor suppressor gene expression to inhibit tumor growth in various solid tumors.